Join host Jim Wilson as he sits down with Nabanita Nawar, co-founder of HDAX Therapeutics, to explore the groundbreaking work in targeting disease driver proteins for novel medicine development. Discover the journey from academic research to entrepreneurial success, and learn about the innovative two-side binding mechanism that could revolutionize treatments for neuropathies and cardiometabolic diseases. Tune in for insights into the challenges and triumphs of biotech entrepreneurship and the future of HDAX Therapeutics.

Ver todos los episodios